$ALTO
Alto Ingredients, Inc. Stock $alto

$alto Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000121390024095907 Filed on November 08, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$251.8M	$318.1M
YoY Change		-20.84%	-5.57%
Cost Of Revenue		$245.9M	$314.0M
YoY Change		-21.69%	-11.98%
Gross Profit		$5.960M	$4.161M
YoY Change		43.23%	-120.97%
Gross Profit Margin		2.37%	1.31%
Selling, General & Admin		$7.510M	$8.488M
YoY Change		-11.52%	14.66%
% of Gross Profit		126.01%	203.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$6.058M	$5.640M
YoY Change		7.41%	-9.9%
% of Gross Profit		101.64%	135.54%
Operating Expenses		$7.510M	$8.488M
YoY Change		-11.52%	14.66%
Operating Profit		-$720.0K	-$4.327M
YoY Change		-83.36%	-84.12%
Interest Expense		-$1.867M	-$2.000M
YoY Change		-6.65%	488.24%
% of Operating Profit
Other Income/Expense, Net		$146.0K	$26.00K
YoY Change		461.54%	-105.7%
Pretax Income		-$2.441M	-$3.489M
YoY Change		-30.04%	-87.56%
Income Tax
% Of Pretax Income
Net Earnings		-$2.441M	-$3.489M
YoY Change		-30.04%	-87.56%
Net Earnings / Revenue		-0.97%	-1.1%
Basic Earnings Per Share		-$0.04	-$0.05
Diluted Earnings Per Share		-$0.04	-$0.05
COMMON SHARES
Basic Shares Outstanding	76.65M shares	76.49M shares	75.91M shares
Diluted Shares Outstanding		73.84M shares	73.19M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$33.59M	$26.20M
YoY Change	28.21%	-7.93%
Cash & Equivalents	$33.59M	$26.16M
Short-Term Investments
Other Short-Term Assets	$6.568M	$6.213M
YoY Change	5.71%	-30.7%
Inventory	$48.01M	$57.09M
Prepaid Expenses
Receivables	$52.04M	$66.07M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$145.2M	$168.2M
YoY Change	-13.71%	-9.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$238.9M	$248.9M
YoY Change	-4.01%	6.6%
Goodwill		$5.970M
YoY Change		0.0%
Intangibles	$8.057M	$8.645M
YoY Change	-6.8%
Long-Term Investments
YoY Change
Other Assets	$6.029M	$6.013M
YoY Change	0.27%	-11.42%
Total Long-Term Assets	$272.3M	$292.9M
YoY Change	-7.05%	9.14%
TOTAL ASSETS
Total Short-Term Assets	$145.2M	$168.2M
Total Long-Term Assets	$272.3M	$292.9M
Total Assets	$417.4M	$461.1M
YoY Change	-9.48%	1.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.21M	$23.99M
YoY Change	-28.28%	37.14%
Accrued Expenses	$14.26M	$16.64M
YoY Change	-14.35%	-24.93%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$45.10M	$58.42M
YoY Change	-22.79%	7.16%
LONG-TERM LIABILITIES
Long-Term Debt	$83.34M	$75.88M
YoY Change	9.84%	65.35%
Other Long-Term Liabilities	$9.302M	$8.870M
YoY Change	4.87%	-11.9%
Total Long-Term Liabilities	$92.64M	$84.75M
YoY Change	9.32%	51.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$45.10M	$58.42M
Total Long-Term Liabilities	$92.64M	$84.75M
Total Liabilities	$153.5M	$163.1M
YoY Change	-5.9%	36.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$782.1M	-$744.6M
YoY Change	5.03%	6.19%
Common Stock	$77.00K	$76.00K
YoY Change	1.32%	2.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$263.9M	$298.0M
YoY Change
Total Liabilities & Shareholders Equity	$417.4M	$461.1M
YoY Change	-9.48%	1.42%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$2.441M	-$3.489M
YoY Change	-30.04%	-87.56%
Depreciation, Depletion And Amortization	$6.058M	$5.640M
YoY Change	7.41%	-9.9%
Cash From Operating Activities	$18.57M	$23.13M
YoY Change	-19.72%	-222.67%
INVESTING ACTIVITIES
Capital Expenditures	$491.0K	$6.640M
YoY Change	-92.61%	-142.92%
Acquisitions
YoY Change
Other Investing Activities	$400.0K	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$91.00K	-$6.640M
YoY Change	-98.63%	803.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-8.394M	-6.720M
YoY Change	24.91%	-70.44%
NET CHANGE
Cash From Operating Activities	18.57M	23.13M
Cash From Investing Activities	-91.00K	-6.640M
Cash From Financing Activities	-8.394M	-6.720M
Net Change In Cash	10.08M	9.770M
YoY Change	3.2%	-123.08%
FREE CASH FLOW
Cash From Operating Activities	$18.57M	$23.13M
Capital Expenditures	$491.0K	$6.640M
Free Cash Flow	$18.08M	$16.49M
YoY Change	9.62%	-587.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	168770000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22597000	usd
CY2024Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	85000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	52611000	usd
CY2023Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	2412000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	58729000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	15466000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	9538000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8498000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	248748000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	alto	Income From Cash Grant IncomeFromCashGrant		usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5628000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	36723000	usd
CY2023Q4	us-gaap	Assets Assets	454241000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	20752000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20205000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4333000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	13849000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6149000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	65288000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	82097000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	19029000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8270000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75703000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	75703000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	76000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2481000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-763913000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	279557000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	454241000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30014000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1040912000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-21467
	dei	Entity Registrant Name EntityRegistrantName	ALTO INGREDIENTS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-2170618
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1300 South Second Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Pekin
	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	61554
	dei	City Area Code CityAreaCode	(916)
	dei	Local Phone Number LocalPhoneNumber	403-2123
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	ALTO
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	76646125	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33591000	usd
CY2024Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	4903000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	50000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	52038000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	48014000	usd
CY2024Q3	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	36000	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	6568000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	145150000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	238892000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19283000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8057000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6029000	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	33369000	usd
CY2024Q3	us-gaap	Assets Assets	417411000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	17205000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14255000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4440000	usd
CY2024Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3394000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5808000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	45102000	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	83342000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	15740000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9302000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	153486000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	174684000	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	18075000	usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	76625000	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76625000	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	77000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1043501000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2481000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-782135000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	263925000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	417411000	usd
CY2024Q3	us-gaap	Revenues Revenues	251814000	usd
CY2023Q3	us-gaap	Revenues Revenues	318127000	usd
	us-gaap	Revenues Revenues	728911000	usd
	us-gaap	Revenues Revenues	949315000	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	245854000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	313966000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	717798000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	931137000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	5960000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	4161000	usd
	us-gaap	Gross Profit GrossProfit	11113000	usd
	us-gaap	Gross Profit GrossProfit	18178000	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7510000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8488000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24403000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24281000	usd
CY2024Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	830000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	830000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	574000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-720000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4327000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12460000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6677000	usd
CY2024Q3	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	1867000	usd
CY2023Q3	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	2000000	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	5170000	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	5299000	usd
CY2023Q3	alto	Income From Cash Grant IncomeFromCashGrant	2812000	usd
	alto	Income From Cash Grant IncomeFromCashGrant	2812000	usd
CY2024Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	146000	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	26000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	358000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	104000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2441000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3489000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17272000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9060000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-2441000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3489000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17272000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9060000	usd
CY2024Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	319000	usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	319000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	950000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	946000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2760000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3808000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18222000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10006000	usd
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73835000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73835000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73191000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73191000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73364000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73364000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73464000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73464000	shares
	us-gaap	Net Income Loss NetIncomeLoss	-17272000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9060000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	17860000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	17382000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	9002000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2463000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	830000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	574000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3650000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2718000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	761000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	793000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	602000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	599000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-23000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-54000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6714000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2644000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-8434000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9536000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4702000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3253000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4424000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4014000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4903000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-11679000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6269000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10229000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9788000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24611000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	400000	usd
	alto	Deferred Purchase Price Payments DeferredPurchasePricePayments	2800000	usd
	alto	Deferred Purchase Price Payments DeferredPurchasePricePayments	3500000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12188000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28111000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-117000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	6847000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2683000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	950000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	946000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1067000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3218000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-6986000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-14664000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45480000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49525000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38494000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34861000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33591000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26162000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4903000	usd
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8699000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38494000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34861000	usd
	us-gaap	Interest Paid Net InterestPaidNet	6211000	usd
	us-gaap	Interest Paid Net InterestPaidNet	6063000	usd
	alto	Proceeds From Sale Of Assets Note Receivable ProceedsFromSaleOfAssetsNoteReceivable	1012000	usd
	alto	Rou Assets Obtained In Exchange For New Lease Obligations ROUAssetsObtainedInExchangeForNewLeaseObligations	7167000	usd
	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	2411000	usd
	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	2185000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	279557000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1142000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	315000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-11725000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	268659000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1646000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-1060000	usd
CY2024Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	316000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-3106000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	265823000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	862000	usd
CY2024Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	319000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-2441000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	263925000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	308089000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	752000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-6000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1682000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	312000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13166000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	293675000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	959000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-120000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1001000	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	315000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	7595000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	300793000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1007000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	5000	usd
CY2023Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	319000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3489000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	297997000	usd
CY2024Q3	alto	Production Capacity ProductionCapacity	350000000	gal
	alto	Essential Ingredient Product Capacity EssentialIngredientProductCapacity	1600000	t
CY2024Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	46887000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	51315000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	50000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	85000	usd
CY2024Q3	alto	Credit Reserve CreditReserve	24000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	8000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	23000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	54000	usd
CY2022Q3	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2022Q3	alto	Initial Purchase Authorization InitialPurchaseAuthorization	10000000	usd
CY2022Q3	alto	Purchase Authorization PurchaseAuthorization	5000000	usd
CY2022Q3	alto	Excess Of Purchase Authorization ExcessOfPurchaseAuthorization	5000000	usd
CY2022Q3	alto	Excess Of Initial Purchase Authorization ExcessOfInitialPurchaseAuthorization	10000000	usd
CY2023Q3	srt	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1249000	shares
CY2023Q3	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	2683000	usd
CY2024Q3	srt	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	2036000	shares
CY2024Q3	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000	usd
	alto	Market Losses MarketLosses	700000000	usd
CY2023Q3	alto	Cash Received CashReceived	2812000	usd
	alto	Cash Received CashReceived	2812000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Estimates and Assumptions</span></i> – The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are required as part of determining the allowance for credit losses, net realizable value of inventory, long-lived asset impairments, valuation allowances on deferred income taxes, the potential outcome of future tax consequences of events recognized in the Company’s financial statements or tax returns, and the valuation of assets acquired and liabilities assumed as a result of business combinations. Actual results and outcomes may materially differ from management’s estimates and assumptions.</p>
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	pure
CY2024Q3	us-gaap	Revenues Revenues	251814000	usd
CY2023Q3	us-gaap	Revenues Revenues	318127000	usd
	us-gaap	Revenues Revenues	728911000	usd
	us-gaap	Revenues Revenues	949315000	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	245854000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	313966000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	717798000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	931137000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	5960000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	4161000	usd
	us-gaap	Gross Profit GrossProfit	11113000	usd
	us-gaap	Gross Profit GrossProfit	18178000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2441000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3489000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17272000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9060000	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6058000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5647000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17860000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17382000	usd
CY2024Q3	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	1867000	usd
CY2023Q3	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	2000000	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	5170000	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	5299000	usd
CY2024Q3	us-gaap	Assets Assets	417411000	usd
CY2023Q4	us-gaap	Assets Assets	454241000	usd
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	203000000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2201000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	27766000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	35765000	usd
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	4788000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	5063000	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	9858000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	10313000	usd
CY2024Q3	us-gaap	Other Inventory OtherInventory	5602000	usd
CY2023Q4	us-gaap	Other Inventory OtherInventory	1470000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	48014000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	52611000	usd
CY2024Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2566000	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2711000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	9002000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2463000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	90572000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	90690000	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	3291000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	3893000	usd
CY2024Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	3939000	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	4700000	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	83342000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	82097000	usd
CY2024Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	27200000	usd
CY2024Q3	alto	Line Of Credit Facility Available For Capital Improvement Project LineOfCreditFacilityAvailableForCapitalImprovementProject	65000000	usd
CY2024Q3	us-gaap	Significant Supply Commitment Remaining Minimum Amount Committed SignificantSupplyCommitmentRemainingMinimumAmountCommitted	6797000	usd
	alto	Indexed Price Sales Contract IndexedPriceSalesContract	44000	t
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	8616000	usd
CY2024Q3	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	36000	usd
CY2024Q3	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	46000	usd
CY2024Q3	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	3000	usd
CY2024Q3	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	13000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	108000	usd
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	138000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	9000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	20897000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-2441000	usd
CY2024Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	319000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2760000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2760000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73835000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73835000	shares
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3489000	usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	319000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3808000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3808000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73191000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73191000	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Net Income Loss NetIncomeLoss	-17272000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	950000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-18222000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18222000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73364000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73364000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
	us-gaap	Net Income Loss NetIncomeLoss	-9060000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	946000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10006000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10006000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73464000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73464000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2024Q3	alto	Income From Cash Grant IncomeFromCashGrant		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	alto	Proceeds From Sale Of Assets Note Receivable ProceedsFromSaleOfAssetsNoteReceivable		usd
	alto	Rou Assets Obtained In Exchange For New Lease Obligations ROUAssetsObtainedInExchangeForNewLeaseObligations		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2024Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000778164

Files In Submission

Name	View Source	Status
0001213900-24-095907-index-headers.html	Edgar Link	pending
0001213900-24-095907-index.html	Edgar Link	pending
0001213900-24-095907.txt	Edgar Link	pending
0001213900-24-095907-xbrl.zip	Edgar Link	pending
alto-20240930.xsd	Edgar Link	pending
ea0220173-10q_altoingred.htm	Edgar Link	pending
ea022017301ex31-1_altoingred.htm	Edgar Link	pending
ea022017301ex31-2_altoingred.htm	Edgar Link	pending
ea022017301ex32-1_altoingred.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
alto-20240930_cal.xml	Edgar Link	unprocessable
alto-20240930_def.xml	Edgar Link	unprocessable
alto-20240930_lab.xml	Edgar Link	unprocessable
alto-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0220173-10q_altoingred_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALTO
Alto Ingredients, Inc. Stock $alto

2024 Q4 Form 10-Q Financial Statement

#000121390024095907 Filed on November 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALTO Alto Ingredients, Inc. Stock $alto

2024 Q4 Form 10-Q Financial Statement

#000121390024095907 Filed on November 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALTO
Alto Ingredients, Inc. Stock $alto